SV Life Sciences Fund IV Cf, L.P.
2 additional placement agents
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days.
- Vintage
- 2022basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised; file 021-43895, sworn by the adviser or filed under this vehicle
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $410Mon the Form ADV filed Mar 31, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 44
- Reported on ADV
- Mar 31, 2022 to Mar 31, 2026
LifecycleActive deployment
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Venture Capital Fund | $420M | 44 | $5.0M | 6% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $396M | 44 | $5.0M | 6% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $400M | 44 | $5.0M | 6% | yes | |
| Mar 31, 2026 | Venture Capital Fund | $410M | 44 | $5.0M | 6% |
- AuditorRSM · BOSTON, Massachusetts, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- AdministratorJuniper Square · SAN FRANCISCO, California, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianBank of America · CHARLOTTE, North Carolina, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- Mar 31, 2026Administrator changed: Juniper Square replaced Apex Group, first reported on the Form ADV filed March 31, 2026 (previous filing March 31, 2025)Administrator changed Fact Form ADV
- Mar 28, 2024Placement Agent changed: Monument Group, Inc. replaced MOSAIC ADVISORS, first reported on the Form ADV filed March 28, 2024 (previous filing March 30, 2023)Placement agent changed Fact Form ADV
- Mar 31, 2022SV Life Sciences Fund IV Cf, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund), GAV $420,228,470Fund first reported on Form ADV Fact Form ADV
Every observation on this vehicle
Relationships across DFX
on 1 other DFX graph
SV Life Sciences Fund IV Cf, L.P. is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Fund first reported on ADV2022-03-31source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.